×
Health / Pharamceutical

Baricitinib in Combination with Remdesivir Reduces Time to Recovery in Hospitalized Patients

Published Sep 14 2020 at 9:09 PM GMT
Drugs.com

Drugs.com @drugs.com

Continue reading at drugs.com
Key
Points
  • Eli Lilly and Company (NYSE: LLY) and Incyte (NASDAQ: INCY) announced today initial data emerging from the Adaptive COVID-19 Treatment Trial (ACTT-2) sponsored by the National Institute of.
Credit
Tags
Continue reading at drugs.com
Trending

Stats

  • Published Sep 14, 2020 9:09 PM GMT